Nectar Social | $10,600,000 | (Jun 6, 2025)
Voltrac | $2,286,772 | (Jun 6, 2025)
Signify Bio | $15,000,000 | (Jun 6, 2025) Certified by Founder
Lodge
Brixton Biosciences
start up
United States
- Cambridge, MA
- 15/05/2024
- Series B
- $33,000,000
Brixton Biosciences is a clinical-stage life sciences company developing novel therapies for chronic and acute pain.
- Industry Biotechnology Research
- Website https://www.brixtonbio.com/
- LinkedIn https://www.linkedin.com/company/brixtonbiosciences/
Allay Therapeutics | $57,500,000 | (Jun 6, 2025)
Flank | $10,000,000 | (Jun 6, 2025)
Obvio | $22,000,000 | (Jun 5, 2025)
Manex AI | $9,142,230 | (Jun 5, 2025)
Filament Syfter | $4,800,000 | (Jun 5, 2025)
Vivrelle | $62,000,000 | (Jun 5, 2025)
Sema4.ai | $25,000,000 | (Jun 5, 2025)
Aive | $13,700,350 | (Jun 5, 2025)
Delpha | $2,000,000 | (Jun 5, 2025)